NCT01352598 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Stereotactic Body Radiotherapy for Prostate Cancer


Sponsors: St. John's Mercy Research Institute, St. Louis	Phases: Phase IV
Indications	Acronym:
Prostate Cancer
Age Groups: Adult Senior	Gender: Male
Names: Radiation: stereotactic body radiotherapy	Enrollment: 30

Additional information about NCT01352598.